Clinical Trial Update: Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for pregabalin in generalized anxiety disorder has completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-12-02